Lisandro D Colantonio1, Christopher M Gamboa1, Joshua S Richman1, Emily B Levitan1, Elsayed Z Soliman1, George Howard1, Monika M Safford2. 1. From Department of Epidemiology, School of Public Health (L.D.C., E.B.L.), Department of Medicine, School of Medicine (C.M.G.), Department of Surgery, School of Medicine (J.S.R.), Department of Biostatistics, School of Public Health (G.H.), University of Alabama at Birmingham; Epidemiological Cardiology Research Center, Wake Forest School of Medicine, Winston-Salem, NC (E.Z.S.); and Department of Medicine, Weill Cornell Medical College, New York (M.M.S.). 2. From Department of Epidemiology, School of Public Health (L.D.C., E.B.L.), Department of Medicine, School of Medicine (C.M.G.), Department of Surgery, School of Medicine (J.S.R.), Department of Biostatistics, School of Public Health (G.H.), University of Alabama at Birmingham; Epidemiological Cardiology Research Center, Wake Forest School of Medicine, Winston-Salem, NC (E.Z.S.); and Department of Medicine, Weill Cornell Medical College, New York (M.M.S.). mms9024@med.cornell.edu.
Abstract
BACKGROUND: Blacks have higher coronary heart disease (CHD) mortality compared with whites. However, a previous study suggests that nonfatal CHD risk may be lower for black versus white men. METHODS: We compared fatal and nonfatal CHD incidence and CHD case-fatality among blacks and whites in the Atherosclerosis Risk in Communities study (ARIC), the Cardiovascular Health Study (CHS), and the Reasons for Geographic and Racial Differences in Stroke study (REGARDS) by sex. Participants 45 to 64 years of age in ARIC (men=6479, women=8488) and REGARDS (men=5296, women=7822), and ≥65 years of age in CHS (men=1836, women=2790) and REGARDS (men=3381, women=4112), all without a history of CHD, were analyzed. Fatal and nonfatal CHD incidence was assessed from baseline (ARIC=1987-1989, CHS=1989-1990, REGARDS=2003-2007) through up to 11 years of follow-up. RESULTS: Age-adjusted hazard ratios comparing black versus white men 45 to 64 years of age in ARIC and REGARDS were 2.09 (95% confidence interval, 1.42-3.06) and 2.11 (1.32-3.38), respectively, for fatal CHD, and 0.82 (0.64-1.05) and 0.94 (0.69-1.28), respectively, for nonfatal CHD. After adjustment for social determinants of health and cardiovascular risk factors, hazard ratios in ARIC and REGARDS were 1.19 (95% confidence interval, 0.74-1.92) and 1.09 (0.62-1.93), respectively, for fatal CHD, and 0.64 (0.47-0.86) and 0.67 (0.48-0.95), respectively, for nonfatal CHD. Similar patterns were present among men ≥65 years of age in CHS and REGARDS. Among women 45 to 64 years of age in ARIC and REGARDS, age-adjusted hazard ratios comparing blacks versus whites were 2.61 (95% confidence interval, 1.57-4.34) and 1.79 (1.06-3.03), respectively, for fatal CHD, and 1.47 (1.13-1.91) and 1.29 (0.91-1.83), respectively, for nonfatal CHD. After multivariable adjustment, hazard ratios in ARIC and REGARDS were 0.67 (95% confidence interval, 0.36-1.24) and 1.00 (0.54-1.85), respectively, for fatal CHD, and 0.70 (0.51-0.97) and 0.70 (0.46-1.06), respectively, for nonfatal CHD. Racial differences in CHD incidence were attenuated among older women. CHD case fatality was higher among black versus white men and women, and the difference remained similar after multivariable adjustment. CONCLUSIONS: After accounting for social determinants of health and risk factors, black men and women have similar risk for fatal CHD compared with white men and women, respectively. However, the risk for nonfatal CHD is consistently lower for black versus white men and women.
BACKGROUND: Blacks have higher coronary heart disease (CHD) mortality compared with whites. However, a previous study suggests that nonfatal CHD risk may be lower for black versus white men. METHODS: We compared fatal and nonfatal CHD incidence and CHD case-fatality among blacks and whites in the Atherosclerosis Risk in Communities study (ARIC), the Cardiovascular Health Study (CHS), and the Reasons for Geographic and Racial Differences in Stroke study (REGARDS) by sex. Participants 45 to 64 years of age in ARIC (men=6479, women=8488) and REGARDS (men=5296, women=7822), and ≥65 years of age in CHS (men=1836, women=2790) and REGARDS (men=3381, women=4112), all without a history of CHD, were analyzed. Fatal and nonfatal CHD incidence was assessed from baseline (ARIC=1987-1989, CHS=1989-1990, REGARDS=2003-2007) through up to 11 years of follow-up. RESULTS: Age-adjusted hazard ratios comparing black versus white men 45 to 64 years of age in ARIC and REGARDS were 2.09 (95% confidence interval, 1.42-3.06) and 2.11 (1.32-3.38), respectively, for fatal CHD, and 0.82 (0.64-1.05) and 0.94 (0.69-1.28), respectively, for nonfatal CHD. After adjustment for social determinants of health and cardiovascular risk factors, hazard ratios in ARIC and REGARDS were 1.19 (95% confidence interval, 0.74-1.92) and 1.09 (0.62-1.93), respectively, for fatal CHD, and 0.64 (0.47-0.86) and 0.67 (0.48-0.95), respectively, for nonfatal CHD. Similar patterns were present among men ≥65 years of age in CHS and REGARDS. Among women 45 to 64 years of age in ARIC and REGARDS, age-adjusted hazard ratios comparing blacks versus whites were 2.61 (95% confidence interval, 1.57-4.34) and 1.79 (1.06-3.03), respectively, for fatal CHD, and 1.47 (1.13-1.91) and 1.29 (0.91-1.83), respectively, for nonfatal CHD. After multivariable adjustment, hazard ratios in ARIC and REGARDS were 0.67 (95% confidence interval, 0.36-1.24) and 1.00 (0.54-1.85), respectively, for fatal CHD, and 0.70 (0.51-0.97) and 0.70 (0.46-1.06), respectively, for nonfatal CHD. Racial differences in CHD incidence were attenuated among older women. CHD case fatality was higher among black versus white men and women, and the difference remained similar after multivariable adjustment. CONCLUSIONS: After accounting for social determinants of health and risk factors, black men and women have similar risk for fatal CHD compared with white men and women, respectively. However, the risk for nonfatal CHD is consistently lower for black versus white men and women.
Authors: Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe Journal: Circulation Date: 2003-11-10 Impact factor: 29.690
Authors: Emily B Levitan; Rikki M Tanner; Hong Zhao; Paul Muntner; Evan L Thacker; George Howard; Stephen P Glasser; Vera Bittner; Michael E Farkouh; Robert S Rosenson; Monika M Safford Journal: Int J Cardiol Date: 2014-04-13 Impact factor: 4.164
Authors: Marco Proietti; Alberto Maria Marra; Eliezer Joseph Tassone; Stefano De Vuono; Salvatore Corrao; Paolo Gobbi; Francesco Perticone; Gino Roberto Corazza; Stefania Basili; Gregory Y H Lip; Francesco Violi; Valeria Raparelli Journal: Am J Cardiol Date: 2015-06-25 Impact factor: 2.778
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Bruce M Psaty; Joseph A Delaney; Alice M Arnold; Lesley H Curtis; Annette L Fitzpatrick; Susan R Heckbert; Barbara McKnight; Diane Ives; John S Gottdiener; Lewis H Kuller; W T Longstreth Journal: Circulation Date: 2015-11-04 Impact factor: 29.690
Authors: Erik B Schelbert; Jie J Cao; Sigurdur Sigurdsson; Thor Aspelund; Peter Kellman; Anthony H Aletras; Christopher K Dyke; Gudmundur Thorgeirsson; Gudny Eiriksdottir; Lenore J Launer; Vilmundur Gudnason; Tamara B Harris; Andrew E Arai Journal: JAMA Date: 2012-09-05 Impact factor: 56.272
Authors: Mark A Hlatky; Roberta M Ray; Dale R Burwen; Karen L Margolis; Karen C Johnson; Anna Kucharska-Newton; JoAnn E Manson; Jennifer G Robinson; Monika M Safford; Matthew Allison; Themistocles L Assimes; Anthony A Bavry; Jeffrey Berger; Rhonda M Cooper-DeHoff; Susan R Heckbert; Wenjun Li; Simin Liu; Lisa W Martin; Marco V Perez; Hilary A Tindle; Wolfgang C Winkelmayer; Marcia L Stefanick Journal: Circ Cardiovasc Qual Outcomes Date: 2014-01-07
Authors: Di Zhao; Wendy S Post; Elena Blasco-Colmenares; Alan Cheng; Yiyi Zhang; Rajat Deo; Roberto Pastor-Barriuso; Erin D Michos; Nona Sotoodehnia; Eliseo Guallar Journal: Circulation Date: 2019-04-02 Impact factor: 29.690
Authors: Ambarish Pandey; Wally Omar; Colby Ayers; Michael LaMonte; Liviu Klein; Norrina B Allen; Lewis H Kuller; Philip Greenland; Charles B Eaton; John S Gottdiener; Donald M Lloyd-Jones; Jarett D Berry Journal: Circulation Date: 2018-01-19 Impact factor: 29.690
Authors: Lisandro D Colantonio; Keri L Monda; Robert S Rosenson; Todd M Brown; Katherine E Mues; George Howard; Monika M Safford; Larisa Yedigarova; Michael E Farkouh; Paul Muntner Journal: Cardiovasc Drugs Ther Date: 2019-04 Impact factor: 3.727
Authors: Jeremy R Van't Hof; Sue Duval; Russell V Luepker; Clarence Jones; Sharonne N Hayes; Lisa A Cooper; Christi A Patten; LaPrincess C Brewer Journal: Mayo Clin Proc Date: 2022-01 Impact factor: 7.616
Authors: Alvin Chandra; Hicham Skali; Brian Claggett; Scott D Solomon; Joseph S Rossi; Stuart D Russell; Kunihiro Matsushita; Dalane W Kitzman; Suma H Konety; Thomas H Mosley; Patricia P Chang; Amil M Shah Journal: J Am Coll Cardiol Date: 2022-02-01 Impact factor: 24.094
Authors: Ashley N Kyalwazi; Eméfah C Loccoh; LaPrincess C Brewer; Elizabeth O Ofili; Jiaman Xu; Yang Song; Karen E Joynt Maddox; Robert W Yeh; Rishi K Wadhera Journal: Circulation Date: 2022-07-18 Impact factor: 39.918
Authors: J Walker Blackston; Monika M Safford; Matthew T Mefford; Elizabeth Freeze; George Howard; Virginia J Howard; David C Naftel; Todd M Brown; Emily B Levitan Journal: Circ Cardiovasc Qual Outcomes Date: 2020-12-11
Authors: Monika M Safford; Evgeniya Reshetnyak; Madeline R Sterling; Joshua S Richman; Paul M Muntner; Raegan W Durant; John Booth; Laura C Pinheiro Journal: Circulation Date: 2020-12-03 Impact factor: 29.690